Nel ASA

Share Issue/Capital Change • Feb 15, 2010

Final results for DiaGenic ASA's subsequent offering

Final results for DiaGenic ASA's subsequent offering

Reference is made the stock exchange notice dated 9 February 2010.

According to the final results of DiaGenic ASA's ("DiaGenic") subsequent

offering, where the subscription period ended 8 February 2010 at 17:30

(CET), DiaGenic has received subscriptions for 7,826,413 new shares.

Thus, the subsequent offering was oversubscribed by 124 per cent.

2,654,569 new shares, equivalent to 76 per cent of the offered shares,

were subscribed for with subscription rights.

The new shares are allocated pursuant to the principles outlined in the

prospectus published on 21 January 2010. Notifications of allocated new

shares in the subsequent offering and the corresponding amount to be

paid by each subscriber, will be mailed to the subscribers today.

The subscribers who are allocated shares will receive one warrant per

share allocated, pursuant to the resolution at the extraordinary general

meeting on 18 December 2009.

Through the subsequent offering DiaGenic will receive a gross proceed of

approximately NOK 9.6 million before transaction costs.

DiaGenic's share capital after the completed subsequent offering is NOK

3,511,826, divided into 70,236,520 shares, each with a nominal value of

NOK 0.05.

The new shares will be listed on Oslo Børs as soon as the share capital

increase has been registered with the Norwegian Register of Business

Enterprises and the new shares have been registered with the Norwegian

Central Securities Depository (VPS). The new shares are expected to be

listed on or about 23 February 2010. The subscribers may not trade the

new shares until they have been paid for and registered on each

subscriber's VPS account.

Argo Securities AS and Orion Securities AS have acted as managers in the

subsequent offering.

For further information, please contact:

Håkon Sæterøy (chairman of the board), telephone +47 92 69 51 75

This information is subject of disclosure requirement according to

section 5-12 of the Norwegian Securities Trading Act.